Dr. Reddy's Laboratories (RDY) Earnings Date, Estimates & Call Transcripts $14.52 +0.10 (+0.66%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$14.60 +0.09 (+0.62%) As of 08/22/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dr. Reddy's Laboratories Earnings Summary Dr. Reddy's Laboratories announced Q1 25/26 earnings on July 23, 2025, reporting an EPS of $0.20, which topped the consensus estimate of $0.18 by $0.02. Quarterly revenue was reported to be $988.82 million, below analysts' expectations of $88.27 billion. With a trailing EPS of $0.66 and a P/E Ratio of 21.99, Dr. Reddy's Laboratories' earnings are expected to grow 2.50% next year, from $0.80 to $0.82 per share. Upcoming Q2 25/26 Earnings DateNov. 4Before Market OpensEstimatedConsensus EPS (Jul. 23) $0.18 Actual EPS (Jul. 23) $0.20 Beat By $0.02 Actual Revenue (Jul. 23) $988.82MQ1 25/26 Earnings ResourcesQ1 25/26 Earnings ReportConference Call Transcript & Audio Interim Report Slide DeckRDY Upcoming EarningsDr. Reddy's Laboratories' next earnings date is estimated for Tuesday, November 4, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Dr. Reddy's Laboratories Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dr. Reddy's Laboratories and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRDY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RDY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Dr. Reddy's Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$1.10$1.10$1.10Q2 20251$0.99$0.99$0.99Q3 20251$1.00$1.00$1.00Q4 20251$0.23$0.23$0.23 FY 2025 4 $3.32 $3.32 $3.32 Q1 20261$0.19$0.19$0.19Q2 20261$0.18$0.18$0.18Q3 20261$0.19$0.19$0.19Q4 20261$0.16$0.16$0.16 FY 2026 4 $0.72 $0.72 $0.72 Q1 20271$0.17$0.17$0.17Q2 20271$0.15$0.15$0.15Q3 20271$0.13$0.13$0.13Q4 20271$0.12$0.12$0.12 FY 2027 4 $0.57 $0.57 $0.57 Q1 20281$0.17$0.17$0.17 Dr. Reddy's Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/4/2025(Estimated)--------7/23/2025Q1 25/26$0.18$0.20+$0.02$0.20$88.27B$988.82M5/9/2025Q4 24/25$0.20$0.22+$0.02$0.22$83.70B$996.17M1/23/2025Q3 24/25$0.19$0.20+$0.01$0.20$975.71M-7/27/2024Q1 24/25$0.22$0.20 -$0.02$1.00$861.68M$919.80M5/7/2024Q4 23/24$0.1720$0.1880+$0.0160$0.94$825.20M$850.00M1/31/2024Q3 23/24$0.1760$0.1980+$0.0220$0.99$827.81M$867.00M10/27/2023Q2 23/24$0.1760$0.2140+$0.0380$1.07$825.94M$832.16M Dr. Reddy's Laboratories Earnings - Frequently Asked Questions When is Dr. Reddy's Laboratories' earnings date? Dr. Reddy's Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 4th, 2025 based off last year's report dates. Learn more on RDY's earnings history. Did Dr. Reddy's Laboratories beat their earnings estimates last quarter? In the previous quarter, Dr. Reddy's Laboratories (NYSE:RDY) reported $0.20 earnings per share (EPS) to beat the analysts' consensus estimate of $0.18 by $0.02. Learn more on analysts' earnings estimate vs. RDY's actual earnings. How can I listen to Dr. Reddy's Laboratories' earnings conference call? The conference call for Dr. Reddy's Laboratories' latest earnings report can be listened to online. Listen to Conference Call How can I read Dr. Reddy's Laboratories' conference call transcript? The conference call transcript for Dr. Reddy's Laboratories' latest earnings report can be read online. Read Transcript How much revenue does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded annual revenue of $3.81 billion. How much profit does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded net income of $663 million. RDY has generated $0.66 earnings per share over the last four quarters. What is Dr. Reddy's Laboratories' price-to-earnings ratio? Dr. Reddy's Laboratories (NYSE:RDY) has a trailing price-to-earnings ratio of 21.99 and a forward price-to-earnings ratio of 18.14. The price/earnings-to-growth ratio is 5.84. What is Dr. Reddy's Laboratories' EPS forecast for next year? Dr. Reddy's Laboratories' earnings are expected to grow from $0.80 per share to $0.82 per share in the next year, which is a 2.50% increase. More Earnings Resources from MarketBeat Related Companies argenex Earnings Date BeOne Medicines Earnings Date BioNTech Earnings Date Insmed Earnings Date Teva Pharmaceutical Industries Earnings Date Summit Therapeutics Earnings Date Genmab A/S Earnings Date Viatris Earnings Date Ascendis Pharma A/S Earnings Date QIAGEN Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NYSE:RDY) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access